2022 Technology Showcase

Check-in (in person)

Join virtually for live broadcast

Welcome Remarks

• Ethan Dmitrovsky, M.D., Director, FNL Frederick National Laboratory
• Michael Salgaller, Ph.D., Unit Supervisor, NCI Technology Transfer Center, Technology Analysis and Marketing Unit, NCI TTC

Keynote Presentation

Douglas Lowy, M.D., Acting Director, NCI

The Voice of the Patient

Sue Scott, cancer survivor, patient advocate, and NCI clinical trial participant

New! Programmatic Session

Introduction by: Michele Newton, Communications Specialist, NCI TTC
Moderator: Michael Salgaller, NCI TTC
Speakers:

• Stephanie Harmon, Ph.D., Scientist, Molecular Imaging Branch, NCI Center for Cancer Research (CCR)
• Marina A. Dobrovolskaia, Ph.D., M.B.A., P.M.P., Laboratory Co-Director, Director of Operations, Immunology Section at the Nanotechnology Characterization Laboratory, FNL
• Eric Stahlberg, Ph.D., Director, Cancer Data Science Initiatives, FNL
• James Gulley, M.D., Ph.D., Co-Director, Center for Immuno-Oncology, NCI CCR

Panel Session 1

Attendee selects one of two concurrent panel sessions.

Panel 1: “How Collaborators Can Tap into Laboratory Resources at the Frederick National Laboratory”

Moderator: Vladimir Popov, Ph.D., Director, Partnership Development Office, FNL
Panelists:

• Dwight V. Nissley, Ph.D., Director, Cancer Research Technology Program, FNL
• Uma Mudunuri, M.S., Director, Advanced Biomedical Computational Science (ABCS), FNL
• Claire Deleage, Ph.D., Scientist, AIDS and Cancer Virus Program, FNL

Option 2: “Government and Venture Funding”

Moderator: Jodie Bollinger, Acting Executive Director, Frederick County Office of Economic Development
Panelists:

• William Bozza, Ph.D., Program Director, NCI SBIR
• Christine Copple, Ph.D., President and CEO, ASM Resources
• Ulyana Desiderio, Ph.D., Director of BioHealth and Life Sciences, MD Department of Commerce
• Katherine Hill Ritchie, M.B.A., Senior Director, Venture Funds, TEDCO

Lightning Pitches

How it works:

• Presenters will each deliver a one-minute "lightning pitch."
• In-person: Attendees can then opt to learn more by stopping by the posters displayed in-person.
• Virtual: The pitch and poster for posters for the Virtual Posters will be presented online only. (Online attendees will have an opportunity to learn more about all of the posters.)

Presentations by NCI Technology Transfer Ambassadors Program (TTAP):

1. "Use of Acetalax for Treatment of Triple Negative Breast Cancer" (E-041-2018)
   Presenter: Sarwat Naz, Ph.D., Technology Transfer Fellow, NCI TTC
   Inventor: Yves Pommier, M.D., Ph.D., Chief, Developmental Therapeutics Branch, NCI CCR
2. "T-cell Receptors Targeting Human Papillomavirus Oncoproteins" (E-176-2014)
   Presenter: Gabrielle O'Brien, TTAP Ambassador
   Inventor: Steven Rosenberg, M.D., Ph.D., Chief, Surgery Branch, NCI CCR
3. "Liquid Biopsy Biomarker to Predict Immunotherapy Efficacy" (E-045-2022)
   Presenter: Andrew Sinkoe, Ph.D., Transition to Industry (T2I) Fellow and Co-Inventor
   Inventors: James Gulley, M.D., Ph.D., Co-Director, Center for Immuno-Oncology; Andrew Sinkoe
4. "Method for Assembling Decellularized Tissue Extracellular Matrix in 3D Tumor Spheroids" (E-127-2022)
   Presenter: Bau-Lin Huang, Ph.D., TTAP Ambassador
   Inventor: Matthew T. Wolf, Ph.D., Stadtman Investigator, Cancer Innovation Laboratory, NCI CCR
5. "Iodonium Analogs as Inhibitors of NADPH Oxidases and Other Flavin Dehydrogenases and Their Use for Treating Cancer" (E-116-2014)
   Presenter: Larisa Gearhart-Serna, Ph.D., M.B.A., Technology Transfer Innovation Fellow, NCI TTC
   Inventor: James Doroshow, M.D., Deputy Director for Clinical and Translation Research, Developmental Therapeutics Branch, NCI
6. "D3 Receptor Agonist Compounds; Methods of Preparation; Intermediates Thereof; and Methods of Use Thereof" (E-077-2019)
   Presenter: Renata Marchette, Ph.D., TTAP Ambassador
   Inventor: Amy Hauck Newman, Ph.D., Scientific Director, Molecular Targets and Medications Discovery Branch, Medicinal Chemistry Section, National Institute on Drug Abuse (NIDA)
7. "Use of Neurotrophic Factor-alpha1/Carboxypeptidase E (CPE) to Treat Alzheimer Disease" (E-200-2021)
   Presenter: Nick Bernier, Ph.D., Technology Transfer Fellow, NCI TTC
   Inventor: Peng Loh, Ph.D., Senior Investigator, Section on Cellular Neurobiology, National Institute of Child Health and Human Development
8. "Sensitive and Economic RNA Virus Detection Using a Novel RNA Preparation Method" (E-195-2020)
   Presenter: Lidia Beka, Ph.D., Technology Transfer Fellow, NCI TTC
   Inventor: Robert Hufnagel, M.D., Ph.D., Lasker Clinical Research Scholar, National Eye Institute (NEI)

Virtual Posters:

1. "Bacteriophage Lambda Vaccine System" E-113-2021
   *Presenter: Susheel Kumar, Ph.D., TTAP Ambassador
   Inventor: Sankar Adhya, Ph.D., Senior Investigator, Laboratory of Molecular Biology, NCI CCR
2. "Immunogens for Use in a High Efficacy HIV Vaccine" (E-160-2018)
   *Presenters: Ali Mehdi, M.B.A., and Swikriti Dasgupta, Business Students, Johns Hopkins University
   Inventor: Genoveffa Franchini, M.D., Senior Investigator, Vaccine Branch, NCI CCR

*Poster developed through the TTAP partnership with the Johns Hopkins Carey Business School "Discovery to Market" course

Networking and Poster Session

Technology Session

Introduction by: Michele Newton, Communications Specialist, NCI TTC
Moderator: Paul Zielinski, M.S., M.B.A., Executive Director, Federal Laboratory Consortium
Speakers:

1. HIV/SIV Specialized Sequencing and Analysis
   Christine Fennessey, Ph.D., Scientist and Manager, AIDS and Cancer Virus Program, FNL
2. Micro-dose Calibrator for Pre-clinical Radiotracer Assays (E-241-2016)
   Stephen Adler, Ph.D., Medical Imaging Scientist, Clinical Monitoring Research Program, Support to NCI Molecular Imaging Program, FNL
3. PIM-Targeted Protacs (E-094-2022)
   John Brognard, Ph.D., Senior Investigator, Laboratory of Cell and Developmental Signaling, NCI CCR
4. Genetically Engineered Myeloid Cells as a Platform to Reprogram Diseased Microenvironments (E-053-2019)
   Rosandra Kaplan, M.D., Senior Investigator, Pediatric Oncology Branch, NCI CCR
5. Polymeric Delivery Platform for Therapeutics (E-097-2017)
   Stephan Stern, Ph.D., D.A.B.T., Director of Research & Development, Head of Pharmacology & Toxicology Section, Nanotechnology Characterization Laboratory, Cancer Research Technology Program, FNL

Panel Session 2

Attendee selects one of two concurrent panel sessions.

Option 1: Non-Traditional and Foundation Sources of Support

Moderator: Stephen Auvil, M.S., M.B.A., Chief Program Operations Officer, TEDCO
Panelists:

• Sujuan Ba, Ph.D., President and CEO, National Foundation for Cancer Research
• Ernesto Chanona, Ph.D., Director of Business Development and Government Affairs, CSSi Life Sciences
• Bret Schreiber, Vice President, Life Sciences and Technology at the Fulton Financial Corporation

Option 2: How to Work with NCI

Moderator: Christie Canaria, Ph.D., Interagency Policy Specialist, National Institute of Standards and Technology
Panelists:

• David Oarr, President, Cytimmune Sciences
• Steven Pavletic, M.D., M.S., Senior Clinician Immune Deficiency Cellular Therapy Program, NCI CCR
• Richard Rodriguez, M.B.A., Associate Director, NCI TTC
• Jeffrey Strovel, Ph.D., CEO, Veralox Therapeutics, Inc.

Closing Remarks and Networking Event

An independently sponsored networking event will take place nearby without involving any resources of the Department of Health and Human Services.